Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b4d191a46e3f46b5b1368233b1fba57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25012123f00395dc4b90398238853295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dd388a5130b0bdede0fdfc6c2af6ed |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
filingDate |
2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4af5452f2ce62056dd7d7d4f5c75fa2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87a0318e61413b060f07d3177630939 |
publicationDate |
2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009073575-A2 |
titleOfInvention |
Methods for treating induced cellular proliferative disorders |
abstract |
Methods are provided for treating a subject with a cellular proliferative disorder that include administering to the subject a therapeutically effective amount of a JAK2 inhibitor and a therapeutically effective amount of a TNF-alpha inhibitor. In addition, methods are provided herein for determining if a subject with a cellular proliferative disorder would benefit from treatment with an agent that inhibits tumor necrosis factor (TNF)-alpha. Methods are also provided for identifying an agent of use in treating a subject with a cellular proliferative disorder or with a predisposition for cellular proliferative disorder. The methods include contacting an isolated cell expressing an activating mutation in the JAK2 protein with a test agent, and detecting the amount of tumor necrosis factor (TNF)-alpha produced by the cell. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233934-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012061833-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011003690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2646029-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106316963-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011323108-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637675-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013541595-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108125923-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4159216-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2701747-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103282036-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103282036-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2646029-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102844317-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102844317-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10391094-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE48285-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2616262-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2701747-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9404149-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143412-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9000179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450337-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE49445-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238628-B2 |
priorityDate |
2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |